In the presence of numerous trigger factors contributing to the exposure of allergodermathosis, there is significant heterogeneity in the phenotypic manifestations of the disease, the severity of its course, as well as the co-morbidity and response to therapy. Objective - to assess the possibility of predicting the severity of allergodermathosis complicated by staphylococcal infection, taking into account the patients' clinical and medical history, bacteriological and immunological indicators. The study included 252 patients with allergodermathosis (95 with atopic dermatitis (AD) and 157 with true eczema (TE)), who were admitted for treatment to the Department of Dermatology of the SE "Institute of Dermatology and Venerology of the National Academy of Medical Sciences of Ukraine" in 2016 - 2019. They carried out the clinical severity scoring of patients using the SCORAD scale, for AD and EASI for TE, bacteriological and immunological analysis with determination of the levels of specific IgE for Staphylococcus aureus auto-strains. It was found that as the severity of the course of allergodermathosis increased, the dysbiotic changes in the skin microbiocenosis increased, which is especially noticeable in patients with severe AD and TE: the isolation frequency of S. aureus strains in this group of patients exceeded the control group 7-11 times in the study of affected areas and 5-10 times in the study of intact ones. The definition of adhesive activity indicators showed that high indices were determined in the group of strains isolated from damaged skin areas of patients with allergodermathosis: AIA - (3.47±0.21) bacteria / erythrocyte and IAM - (4.22±0.32) bacteria / erythrocyte. It was revealed that the severity of the course of allergodermathosis correlated with the levels of specific IgE for S. aureus auto-strains.
Download full-text PDF |
Source |
---|
Curr Cardiol Rep
January 2025
Division of Heart and Vascular, Metrohealth Medical Center, 2500 Metrohealth Dr, Cleveland, OH, 44109, USA.
Purpose Of Review: Eosinophilic myocarditis (EM) is a rare and heterogeneous form of inflammatory heart disease that can present with a wide range of severity. Current literature is limited to case reports or small case series that outline the evaluation process, disease course, and the nonstandardized treatments trialed. This review aims to concisely summarize the current literature on EM including an update on maintenance therapy for refractory or recurrent disease.
View Article and Find Full Text PDFHernia
January 2025
Department of General and Abdominal Surgery, Clinic for General and Abdominal Surgery, University Hospital Brandenburg an der Havel, Hochstrasse 29, 14770, Brandenburg an der Havel, Germany.
Background: Hernias are among the most common surgical conditions worldwide, with significant prevalence in Africa. However, according to recent WHO statistics, Africa faces a critical shortage of trained surgeons. Structured surgical training programs are also scarce.
View Article and Find Full Text PDFLiver Int
February 2025
Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hanover, Germany.
Background And Aims: Chronic hepatitis D virus (HDV) infection can cause severe liver disease. With new treatment options available, it is important to identify patients at risk for liver-related complications. We aimed to investigate kinetics and predictive values of novel virological and immunological markers in the natural course of chronic HDV infection.
View Article and Find Full Text PDFHematol Rep
January 2025
Operations Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
The outcome of refractory/relapsed systemic Anaplastic Large Cell Lymphoma (R/R-sALCL), especially for anaplastic lymphoma kinase-1 (ALK-1)-negative disease, remains dismal even after autologous hematopoietic stem cell transplantation (AHSCT). The intensification of both salvage and conditioning regimens, without increasing the toxicity, could improve the outcome of AHSCT in R/R-sALCL. Based on the successful experience of the incorporation of antiD20 monoclonal antibodies in the treatment of B-Cell Lymphomas, we designed a salvage and conditioning regimen incorporating the antiCD30-conjugated antibody (Brentuximab Vedotin, BV) to standard chemotherapy regimens, and we describe herein the clinical course of a patient with AKL-ve, R/R-sALCL, who received salvage regimen BV + DHAP, followed by AHSCT with preparative regimen consisted of BV plus standard BEAM.
View Article and Find Full Text PDFACR Open Rheumatol
January 2025
Amgen, Inc (formerly Horizon Therapeutics plc), Deerfield, Illinois.
Objective: Patients with uncontrolled gout have few treatment options. Pegloticase lowers serum urate (SU) levels, but antidrug antibodies limit SU-lowering response and increase infusion reaction (IR) risk. Methotrexate (MTX) cotherapy increases pegloticase response rates and lowers IR risk in pegloticase-naïve patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!